Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure

Published:2024-06-05 Issue:4 Volume:18 Page:667-676
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Bae June Hwa¹^ORCID,Park Jung-Bin¹^ORCID,Baek Ji Eun¹^ORCID,Hong Seung Wook¹^ORCID,Park Sang Hyoung¹²^ORCID,Yang Dong-Hoon¹^ORCID,Ye Byong Duk¹²^ORCID,Byeon Jeong-Sik¹^ORCID,Myung Seung-Jae¹^ORCID,Yang Suk-Kyun¹²^ORCID,Hwang Sung Wook¹²^ORCID

Affiliation:

1. Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

2. Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Funder

National Research Foundation of Korea

Ministry of Education

Publisher

The Editorial Office of Gut and Liver

Link

https://pdf.medrang.co.kr/GNL/2024/018/GNL018-04-667.pdf

Reference42 articles.

1. Crohn's disease

2. Ulcerative colitis

3. Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

4. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

5. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP